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Summary 
This report describes the influence of bombesin on the 
gross behavior of goldfish, frogs, mice, rats, guinea 
pigs, rabbits, chicks, pigeons and monkeys. Goldfish, 
frogs, chicks and pigeons were overtly unaffected by 
bombesin given centrally and/or peripherally. Mice, 
rats, guinea pigs, rabbits and monkeys responded quickly 
to intracerebroventricular (i.c.v.) and/or intrathecal 
(i.th.) administration of bombesin by displaying a range 
of behaviors suggestive of altered skin sensation. In 
mice, bombesin was essentially equipotent as a scratch 
inducer by i.c.v, and i.th. routes (A~0=0.010-0.019 ~g) 
but 6800 times less potent i.p. In rats, bombesin- 
induced grooming and scratching behaviors were shown to 
be qualitatively different from those associated with 
ACTH-(I-24) and thyrotropin releasing hormone. Spantide 
and [D-Arg ~, D-Pro~ D-TrpT'~ Leu~']substance P (both at 0.20, 
0.50 and 0.80 ~g i.c.v.), two proposed bombesin receptor 
antagonists, did not markedly influence bombesin-induced 
scratching or hypothermia in rats. 
Bombesin is a tetradecapeptide which was originally isolated 
from frog skin (i). In keeping with its designation as a brain- 
gut peptide, bombesin promotes homeostasis (2) by regulating 
gastrointestinal function (3-5), food intake (6-8), blood glucose 
levels (9,10) and body temperature (11-13). 
Mice and rats have been mainly used in studies involving 
bombesin and behavior. For example, central injection of bombesin 
to rats increases locomotor activity when the animals are tested 
in small Plexiglas chambers (14). The increased locomotion can be 
antagonized if the animals are pretreated with neuroleptics such 
as haloperidol or fluphenazine (15). The nature of the testing 
environment is important since bombesin suppresses ambulation (and 
rearing) if the rats are run in an open-field apparatus (16). 
The most obvious response of mice (17-20) and rats (11,21-23) 
to i.c.v, bombesin is a remarkable display of grooming and scratch 
ing during which the animals seem preoccupied with skin sensation. 
Does bombesin affect the ongoing behavior of other species in a 
similarly dramatic fashion? This question provided the stimulus 
for the present investigation. Additionally, quantitative inform- 
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ation is provided on scratching in mice when bombesin is given by 
one of three routes - i.c.v., i.th. and i.p. Second, qualitative 
information is provided on scratching in rats by comparing the 
behavioral syndromes associated with bombesin, adrenocorticotropin 
[specifically, ACTH-(I-24)] (24) and thyrotropin releasing hormone 
(TRH)(25) . And third, two proposed bombesin receptor antagonists, 
spantide ([D-Arg~ D-Trp~,~ Leu~]substance P) {26) and DAPTL-SP 
([D-Arg~ D-Pro~ D-Trp 7'9, Leu~]substance P (27) are tested against 
bombesin-induced scratching and hypothermia in rats. 
Materials and Methods 
Compounds Naloxone HCl (kindly supplied by Endo) was dissolved in 
saline. The following peptides were dissolved in distilled water 
immediately before injection: ACTH-(I-24) (courtesy of H. Kuijs, 
Organon, Holland); bombesin (Sigma); DAPTL-SP (Bachem) ; spantide 
(Peninsula) and TRH (Sigma). 
Goldfish Eight goldfish of the comet variety, weighing 3-5 g, 
were obtained from a local supplier. They were housed in a tank 
(under constant aeration) in a laboratory for 5 days. A standard 
light-dark cycle was maintained with a timer-regulated light 
period from 07.00 hr to 19.00 hr. Experiments took place between 
i0.00 hr and noon. Bombesin (5 pl) was injected s.c. in the bell~ 
The doses were 0.i0 pg (n=2), 5 pg (n=2) and 25 ~g (8.3 mg/kg; 
n=4) . The goldfish were observed for 2 hr post-injection. 
Frogs Male frogs (Rana pipiens; 25-40 g) were purchased from West 
Jersey Biological Supply Farm, Wenonah, N.J. Two days before 
experimentation, they were weighed and placed in individual 
plastic observation boxes (25 cm long; 20 cm wide; 15 cm high) 
containing water to a depth of 1 cm. Environmental temperature 
was maintained at 20±0.5°C by means of an automatic thermostat. 
Lights were on between 9.00 hr and 18.00 hr. Bombesin was given 
i.th. at the articulation between the seventh and eighth vertebrae 
(28) (0.i0 ~g in a volume of 1 pl; n~6) or s.c. (0.25 mi/25 g; i0 
mg/kg; n=4). The frogs were observed over the following 1 hr. 
Mice Male ICR mice (22-28 g) (Temple University Skin and Cancer 
Hospital) were each placed in an individual Plexiglas observation 
box (22 cm long; 18 cm wide; 25 cm high) and allowed to habituate 
for at least 15 min. They were injected with bombesin i.th. (29) 
(5 pl) , i.c.v. (30) (5 ~i) or i.p. (0.25 mi/25 g) and immediately 
observed (i.c.v. and i.th.) , or observed at +5 min (i.p.) , for 15 
min. Four mice were scored simultaneously. The grooming and 
scratching shown by each animal was monitored for 5 sec out of 
every 20 sec. A positive score was given if the mouse groomed or 
scratched during each interval. Results are presented as percent 
of the maximum (i.e., 45) possible number of grooming/scratching 
episodes (%MGE). Four mice were used per dose of bombesin. As0 
values were estimated by linear regression analysis (31). Exper- 
iments took place between 14.00 hr and 18.00 hr. 
Rats Male Sprague Dawley albino rats (180-200 g; Zivic-Miller) 
were anesthetized with ketamine HCl (i00 mg/kg i.p.) and placed 
in a Kopf stereotaxic frame. A polyethylene cannula (PE i0) was 
positioned in a lateral cerebral ventricle of each rat as prev- 
iously described (32). After surgery, the animals were housed 
individually and allowed 5-7 days for recovery prior to i.c.v. 
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administration of ACTH-(I-24), bombesin or TRH (each agent in 5 W1 
water then a 3 Pl wash with more water). When appropriate, DAPTL- 
SP, spantide or water was given i.c.v. 5 min before a standard 
dose of bombesin (0.i0 Pg i.c.v.) or water. Behavior of rats 
(n=10) was monitored (beginning 5 min after each bombesin inject- 
ion) for 5 sec out of every 20 sec over a 30 min observation 
period and quantitated as previously described (33). Cannula 
placements were verified after each experiment by injecting 
methylene blue and checking for distribution within the cerebro- 
ventricular system. 
Additional rats were infused with bombesin (0.18 wg/hr for 7 
days) (23) to the caudal region of the Sylvian aqueduct from a 
s.c. implanted osmotic minipump (Alzet 2001) (34), then challenged 
with DAPTL-SP (0.5 pg i.c.v., n=3) and observed for 30 min. 
The possibility that spantide and/or DAPTL-SP might prevent 
bombesin-induced hypothermia was studied. Rats (n=5) were each 
placed in an individual Plexiglas observation box (26 cm long; 20 
cm wide; 30 cm high) and allowed to habituate to a temperature of 
6±2°C for 1 hr (ii). Rectal temperatures were taken several times 
with a thermistor probe to familiarize the animals with the proc- 
edure. The baseline (zero time) temperature was noted (with the 
probe inserted 6 cm into the rectum) then test agent or water was 
given i.c.v. 20 min before bombesin (0.i0 pg i.c.v.) or water. 
Temperatures were taken at 30, 60, 90 and 120 min. 
In a tolerance experiment, additional rats (n=6] received a 
continuous i.c.v, infusion of water (i wl/hr) or bombesin (0.18 
wg/hr) (23) from a s.c. implanted Alzet 2001 minipump. After 7 
days, they were challenged with bombesin (0.i0 ~g i.c.v.) and 
rectal temperatures were taken at an ambient temperature of 6±2°C 
as outlined above. 
Guinea pigs Male albino guinea pigs (n:4) (180-200 g; Charles 
River) were each cannulated in the lateral cerebral ventricle (35) 
in a manner similar to that described for rats. They lived in 
individual Plexiglas boxes (26 cm long; 20 cm wide; 30 cm high) 
and were observed in these boxes during the 60 min after injection 
of bombesin (0.50 ~g in 5 W1 water). 
Rabbits Three male New Zealand albino rabbits (2-4 kg; Biosearch, 
Philadelphia) were anesthetized with pentobarbital (30 mg/kg i.p.). 
A polyethylene cannula was inserted into the left lateral cerebro- 
ventricle (36) and behavioral experiments started 5 days later. 
Bombesin (0.i0 pg) was given i.c.v., in i00 pl of water. This was 
followed by a i00 W1 wash with more water. Rabbits were placed in 
trash cans (diameter: 35 cm; height: 55 cm) with which they had 
been familiarized and their gross behavior was observed for 1 hr. 
Chicks Groups of 5 white leghorn cockerels (2-3 days old; Moyers 
Chicks, Quakertown, PA) were placed in open makrolon observation 
boxes. The floor of each box was covered with sawdust. Water and 
food crumbs were made available throughout the experiment. After 
a 30 min control period, each chick was injected s.c. on one side 
of the abdomen with water (0.25 mi/25 g) or bombesin (i, 5 and 
12.5 mg/kg). The overt behavior of the birds was observed for 60 
min. The study was repeated with different chicks (n=5) when they 
were ii days old. 
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Pigeons Two White Carneaux pigeons were selected from the group 
of birds being used in the evaluation of psychoactive agents in 
the Department of Pharmacology, University of Michigan. Both pig- 
eons had previously received a variety of compounds. One dose of 
bombesin (I00 ~g) was given i.c.v. (37) in the present study and 
the birds were observed for the following 60 min. 
Monkeys Four rhesus monkeys (4-6 kg) were chosen from the colony 
of morphine-dependent animals being used to assess the physical 
dependence liability of new analgesics at the University of Mich- 
igan. A stainless steel cannula was implanted in a lateral cere- 
bral ventricle of each monkey as previously described (38,39) . 
(Cannula placements were subsequently verified by radiography). 
Two doses of bombesin (750 pg and 1 mg) were tested in the monkeys 
(n=2) about 2 hr after their regular maintenance dose of morphine 
(3 mg/kg s.c.). The animals were observed for the ensuing 4 hr. 
Results 
Bombesin caused no overt effects when given to goldfish (0.i0, 
5 and 25 pg s.c.), frogs (0.i0 ~g i.th. and i0 mg/kg s.c.), chicks 
(i, 5 and 12.5 mg/kg s.c.) and pigeons (i00 pg i.c.v.) . 
The most obvious behavior induced by centrally administered 
bombesin in mice was an immediate and incessant scratching of the 
flanks and neck area with the hindpaws (Fig. IA) . Facial grooming 
with the forepaws was also greatly increased. Oral preening of 
the tail (Fig. 2A) was frequent when bombesin was given i.th.; 
less so when given i.c.v.; and infrequent when given .... 
Scratching/grooming was dose-related (Fig. 3). AS0 values (and 
95% confidence limits) for bombesin by i.c.v., i.th. and i.p. 
routes were 0.010 ~g {0.003-0.030) [i.e. 6 pmole (1.8-18)] , 0.019 
~g (0.010-0.30) and 68 ~g (32-147) , respectively. 
In rats, bombesin (0.05, 0.i0 and 0.50 pg) caused excessive 
scratching ~ the head and neck area by the hindpaws within i-3 min 
of injection (Fig. IB). The rats frequently licked their hindpaws 
before scratching. Facial grooming (with forepaws), body washing 
(with tongue and teeth), forepaw tremor, stretching and wet-dog 
shaking also occurred. These behaviors lasted 45-60 min. 
TRH and ACTH-(I-24) also caused Jncreased grooming, forepaw 
tremor and body shaking in rats but these syndromes lacked the 
compulsive scratching component so characteristic of bombesin. 
TRH 13 and i0 ~g i.c.v.) provoked extensive face washing (Fig. iC), 
licking the front paws and oral stereotypies. These behaviors 
appeared within 5 min of injection and lasted 10-20 min. The 
increased grooming associated with ACTH-(I-24) (1.5 and 3 pg L~) 
in rats was similar to normal grooming in that the rats thoroughly 
washed the face and entire body (Fig. ID) but the bouts were long- 
er. Onset time was 12-17 min and the effects lasted about I hr. 
DAPTL-SP and spantide (both at 0.20, 0.50 and 0.80 ~g i.c.v.) 
were tested against the grooming/scratching caused by bombesin in 
rats. Higher doses of DAPTL-SP and spantide (e.g. 2 ~g) elicited 
behavioral effects which precluded further testing. These effects 
were immediate prostration and barrel rotation. Even at 0.50 and 
0.80 pg, both agents provoked, on occasion, barrel rotation and 
motor impairment. These animals were rejected. Neither DAPTL-SP 
nor spantide attenuated bombesin-induced grooming/scratching. 
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FIG. i 
Scratching and grooming behavior in mouse (A) and rat 
(B-D) . (A) Bombesin, 0.02 ~g i.th. (B) Bombesin, 0.i0 
~g i.c.v. (C) TRH, i0 ~g i.c.v. (D) ACTH, 3 ~g i.c.v. 
FIG. 2 
Grooming and scratching behavior in mouse (A) and gulnea 
pig (B). (A) Bombesin, 0.02 ~g i.th. (b) Bombesin, 0.50 
~g i.c.v. 
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FIG. 3 
Grooming/scratching induced in mice (n=4) by intra- 
cerebroventricular, intrathecal and intraperitoneal 
administration of bombesin. %MGE is the percent of 
the maximum possible number of grooming/scratching 
episodes in 15 min. 
DAPTL-SP (0.50 ~g i.c.v.} evoked no overt change in behavior 
when given to rats that had received a central infusion of bombesin 
for 7 days. 
DAPTL-SP and spantide (both at 0.20, 0.50 and 0.80 ~g i.c.v.) 
were again ineffective as bombesin antagonists against a second 
endpoint - bombesin-induced hypothermia in rats placed in an 
environment of 6±2°C. 
It is known that tolerance does not develop to the scratching 
associated with bombesin administration to rats {23,40). This was 
confirmed in the present study and contrasts with the demonstrated 
development of tolerance to bombesin-induced hypothermia (in the 
same rats) at 6±2°C (Fig. 4). 
In guinea pigs, bombesin (0.50 ~g i.c.v.} caused immediate 
behavioral activation. Within 3 min, all four animals displayed 
excessive scratching of the head and neck area with the hindpaws 
(Fig. 2B), face washing with forepaws and wet-dog shaking. One 
guinea pig stretched and writhed several times at +32 min. The 
syndrome lasted 30-45 min; thereafter, the animals were quiet and 
all showed ptosis. 
Bombesin (0.i0 ~g i.c.v.) caused immediate behavioral agit- 
ation and rearing in all three rabbits studied. Within 2 min, the 
animals displayed face washing with forepaws. Between i0 and 30 
min, face washing, scratching of the flanks and neck with the hin~ 
paws, and wet-dog shaking, occurred every 3-4 min, that is, in a 
regular fashion but n~ so frequently as we observed in mice, rats 
and guinea pigs. 
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FIG. 4 
Development of tolerance to the hypothermic 
effect of bombesin. Rats (n=6) received an 
i.c.v, infusion of water {.) or bombesin (0) 
(0.18 pg/hr) from a s.c. osmotic minipump. 
After 7 days, both groups received bombesin 
(0.i0 pg i.c.v.) and rectal temperatures 
were taken for 2 hr at 6±2°C. 
Bombesin (750 pg and 1 mg i.c.v.) altered the behavior of 
four rhesus monkeys in a dramatic manner. During injection of the 
peptide (with the monkey in a restraining chair), a transient red- 
ness appeared about the face {and particularly the eyes) of the 
animals. In the cage, they immediately spat out food that was 
stored in their cheeks, became agitated and restless and began 
pacing. Within 2-5 min, the monkeys rubbed their eyes with the 
back of their wrists. Thereafter, they scratched the face, ears, 
head, soles of feet, and entire body; and rubbed their face and 
palms along the bars of the cage. On average, one scratching/ 
rubbing episode occurred per min (Fig. 5). There was evidence of 
abdominal discomfort (protecting the stomach, retching, vomiting) 
as well as piloerection, abnormal postures, tongue movements and 
hypothermia. The syndrome lasted at least 4 hr. 
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FIG. 5 
Scratching/grooming behaviors in morphine-dependent rhesus 
monkeys 30-60 min after bombesin (750 pg i.c.v.) 
Discussion 
Bombesin causes mice (17-20) and rats (11,21-23) to groom and 
scratch. The present experiments have shown that bombesin is a 
potent inducer of scratching/grooming in certain other animals as 
well. Thus, mice, rats, guinea pigs, rabbits and monkeys quickly 
respond to small doses of centrally administered bombesin with 
behaviors which, outwardly, are suggestive of changes in skin 
sensation. The overt behavior of goldfish, frogs, chicks and 
pigeons appears to be unaffected by the peptide, at least under 
our experimental conditions. In this context, it is of interest 
that locomotor activity of the teleost fish, Catostomus commerson~ 
is not markedly influenced by i.c.v, application of bombesin (5 p~ 
g) (41). Also, De Caro et al. (42) studied bombesin in the pigeon 
at doses (0.01-I ~g i.c.v.) lower than we used (I00 ~g i.c.v.). 
These workers found bombesin to be dipsogenic, and behaviorally 
inactive, in this species. 
in mice, bombesin is essentially equipotent as a scratch- 
inducer by i.c.v. (A50=0.010 pg) and i.th. (A50-0.019 pg) routes 
of administration. Scratching can be elicited by i.p. injection 
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but a dose 6800 times greater than the i.c.v, dose is required. 
O'Donohue et al. (20) studied bombesin after i.th. administration 
to mice and concluded that this peptide, like substance P, is a 
neurotransmitter of primary sensory afferents. Scratching induced 
by bombesin and substance P in mice can be differentiated pharm- 
acologically since morphine attenuates the behavior associated 
with substance P (43) but not that caused by bombesin (17). It 
remains to be seen if agonists which show selectivity for kappa 
opioid receptors will antagonize bombesin-induced scratching in 
mice. This is certainly the case in rats where bombesin-induced 
scratching is antagonized in a stereospecific and dose-related 
manner by benzomorphan kappa agonists but not by many standard 
opioids and opioid peptides (44). 
As in mice, bombesin acts at spinal, as well as supraspinal, 
levels in rats to cause scratching (45). The i.c.v, and i.th. A50's 
for the peptide in mice and rats are comparable (45). The behav- 
ioral effects displayed by rats after bombesin can easily be dis- 
tinguished from those provoked by ACTH-(I-24) and TRH (see result). 
What makes rats react in such a startling yet distinctive manner 
to these peptides? How and where does the animal perceive the 
stimulus that triggers the excessive behaviors? Why does tolerance 
not develop to bombesin-induced scratching just as it does to the 
hypothermia (46)? We do not have answers to these questions at the 
moment. The availability of bombesin antagonists that work in vivo 
would obviously help. The two agents tested in the present study - 
spantide (26) and DAPTL-SP (27) - proved disappointing. We were 
unable to demonstrate antagonism of bombesin-induced scratching or 
hypothermia over the dose range, 0.20-0.80 ~g i.c.v. Higher doses 
caused barrel rotation (47) and motor impairment to such an extent 
that behavioral experiments were rendered meaningless. In contrast 
to our experience, Yachnis et al. (48) recently used a sample of 
spantide (2 ~g i.c.v. - Peninsula) that gave no side effects and 
they were able to prevent bombesin-induced grooming and hypo- 
thermia in rats. 
A 5-min infusion of bombesin (1-4 ~g/kg) had no marked effect 
on the gross behavior of baboons (49). We found that bombesin 
caused extensive scratching in nonwithdrawn morphine-dependent 
rhesus monkeys after i.c.v, administration of 750 and i000 ~g. 
This behavior has previously been noted in monkeys undergoing 
withdrawal from certain kappa agonists (50). The other signs and 
symptoms observed in the present study - restlessness, abdominal 
discomfort, vomiting, piloerection, abnormal postures and hypo- 
thermia - may well be acute effects of bombesin in this species. 
They also constitute a passable morphine-like abstinence syndrome. 
Is bombesin precipitating true abstinence, quasi-abstinence (51) or 
a bit of both? Testing the peptide in drug-naive monkeys should 
provide the answers. 
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